DZ3083A1 - New protease inhibitor compounds, process for their preparation and pharmaceutical compositions containing them - Google Patents
New protease inhibitor compounds, process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- DZ3083A1 DZ3083A1 DZ000030A DZ000030A DZ3083A1 DZ 3083 A1 DZ3083 A1 DZ 3083A1 DZ 000030 A DZ000030 A DZ 000030A DZ 000030 A DZ000030 A DZ 000030A DZ 3083 A1 DZ3083 A1 DZ 3083A1
- Authority
- DZ
- Algeria
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- protease inhibitor
- inhibitor compounds
- Prior art date
Links
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/16—Eight-membered rings
- C07D313/18—Eight-membered rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12069999P | 1999-02-19 | 1999-02-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
DZ3083A1 true DZ3083A1 (en) | 2004-06-02 |
Family
ID=22392011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DZ000030A DZ3083A1 (en) | 1999-02-19 | 2000-02-16 | New protease inhibitor compounds, process for their preparation and pharmaceutical compositions containing them |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1153022A4 (en) |
JP (1) | JP2002537297A (en) |
AU (1) | AU3235100A (en) |
CO (1) | CO5271679A1 (en) |
DZ (1) | DZ3083A1 (en) |
HK (1) | HK1042695A1 (en) |
PE (1) | PE20001486A1 (en) |
WO (1) | WO2000049011A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7168084B1 (en) | 1992-12-09 | 2007-01-23 | Sedna Patent Services, Llc | Method and apparatus for targeting virtual objects |
US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
US6583137B1 (en) | 1999-11-10 | 2003-06-24 | Smithkline Beecham Corporation | Protease inhibitors |
JP2003513924A (en) | 1999-11-10 | 2003-04-15 | スミスクライン・ビーチャム・コーポレイション | Protease inhibitor |
JP2003513971A (en) | 1999-11-10 | 2003-04-15 | スミスクライン・ビーチャム・コーポレイション | Protease inhibitor |
IL150964A0 (en) | 2000-03-21 | 2003-02-12 | Smithkline Beecham Corp | Protease inhibitors |
JP2004520439A (en) * | 2000-11-17 | 2004-07-08 | メディヴィル・アクチボラグ | Cysteine protease inhibitor |
CA2428863A1 (en) * | 2000-11-17 | 2002-05-23 | Medivir Uk Limited | Cysteine protease inhibitors |
DE102004021338A1 (en) | 2003-05-27 | 2005-03-03 | Merck Patent Gmbh | New pyran compounds are useful as components in liquid crystalline media, preferably in optoelectronic displays |
DE502004001386D1 (en) * | 2003-05-27 | 2006-10-19 | Merck Patent Gmbh | Pyranderivative with exocyclic double bond |
EP1757284A1 (en) | 2005-08-25 | 2007-02-28 | Santhera Pharmaceuticals (Schweiz) AG | Use of N-(dibenz(b,f)oxepin-10ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5021432A (en) * | 1988-04-26 | 1991-06-04 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzopyran compound and its pharmaceutical use |
AU6252794A (en) * | 1993-03-03 | 1994-09-26 | Eli Lilly And Company | Balanoids |
US5612370A (en) * | 1995-06-07 | 1997-03-18 | Bristol-Myers Squibb Company | Phenylglycine and phenylalaninen amido benzopyran derivatives |
AR013079A1 (en) * | 1997-05-06 | 2000-12-13 | Smithkline Beecham Corp | SUBSTITUTED DERIVATIVES OF TETRAHIDROFURANO-3-ONAS, TETRAHIDROPIRANO-3- ONAS AND TETRAHIDROTIOFEN-3-ONAS, A PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION OF A MEDICINAL PRODUCT USEFUL AS INTERMEDIATE PROTEIN INHIBITORS |
-
2000
- 2000-02-16 DZ DZ000030A patent/DZ3083A1/en active
- 2000-02-17 JP JP2000599751A patent/JP2002537297A/en not_active Withdrawn
- 2000-02-17 EP EP00910222A patent/EP1153022A4/en not_active Withdrawn
- 2000-02-17 WO PCT/US2000/004133 patent/WO2000049011A1/en not_active Application Discontinuation
- 2000-02-17 AU AU32351/00A patent/AU3235100A/en not_active Abandoned
- 2000-02-18 CO CO00011383A patent/CO5271679A1/en not_active Application Discontinuation
- 2000-02-18 PE PE2000000128A patent/PE20001486A1/en not_active Application Discontinuation
-
2002
- 2002-03-28 HK HK02102419.7A patent/HK1042695A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU3235100A (en) | 2000-09-04 |
HK1042695A1 (en) | 2002-08-23 |
JP2002537297A (en) | 2002-11-05 |
WO2000049011A1 (en) | 2000-08-24 |
EP1153022A4 (en) | 2002-03-27 |
EP1153022A1 (en) | 2001-11-14 |
CO5271679A1 (en) | 2003-04-30 |
PE20001486A1 (en) | 2001-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DZ3052A1 (en) | Compounds new inhibitors of metalloproteases, process for their preparation and pharmaceutical compositions containing them. | |
DZ2891A1 (en) | New substituted tetrahydroquinoline derivatives, process for their preparation and pharmaceutical compositions containing them. | |
DZ2963A1 (en) | New substituted bicyclic derivatives, process for their preparation and pharmaceutical compositions containing them. | |
DZ2890A1 (en) | 4-Carboxamino-2-substituted-1,2,3,4-tetrahydroquinoline, process for their preparation and pharmaceutical compositions containing them. | |
MA26659A1 (en) | NOVEL BENZIMIDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR THEIR PREPARATION. | |
DZ2634A1 (en) | New pleuromutilin derivatives, process for their preparation and pharmaceutical compositions containing them. | |
DZ2773A1 (en) | New pyrazolopyrimidinones process for their preparation and pharmaceutical compositions containing them. | |
DZ2866A1 (en) | New 1-Aryl-3-arylmethyl-1,8-naphthyridine-4- (1H) -ones, process for their preparation and pharmaceutical compositions containing them. | |
DZ3016A1 (en) | Compounds new monoamine reabsorption inhibitors, process for their preparation and pharmaceutical compositions containing them. | |
DZ2889A1 (en) | 4-Carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines, process for their preparation and pharmaceutical compositions containing them. | |
DZ3009A1 (en) | New heteroaryl substituted quinoline-2-one derivatives, process for their preparation and pharmaceutical compositions containing them. | |
DZ2197A1 (en) | 6-Phenylpyridyl-2-amine derivatives, process for their preparation and pharmaceutical compositions containing them. | |
DZ2128A1 (en) | New compounds, process for their preparation and pharmaceutical compositions containing them. | |
DZ1889A1 (en) | New quinoline derivatives, process for their preparation and pharmaceutical compositions containing them. | |
DZ3045A1 (en) | Novel i-3-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them. | |
DZ2465A1 (en) | New pyrazolopyrimidinones process for their preparation and compositions containing them. | |
DZ3020A1 (en) | New oxamic acids, process for their preparation and pharmaceutical compositions containing them. | |
DZ3042A1 (en) | New isothiazole derivatives, process for their preparation and pharmaceutical compositions containing them. | |
DZ2300A1 (en) | Substituted 6,5-heterobicyclic derivatives, process for their preparation and pharmaceutical compositions containing them. | |
DZ2299A1 (en) | Substituted 6,6-heterobicyclic derivatives, process for their preparation and pharmaceutical compositions containing them. | |
DZ2962A1 (en) | New 3-azabicycloÄ3,1,0Ühexane derivatives, process for their preparation and compositions containing them. | |
CH689805A8 (en) | Paroxetine methanesulfonate, process for its preparation and pharmaceutical compositions containing it. | |
DZ1957A1 (en) | New piperidine derivatives, process for their preparation and pharmaceutical compositions containing them. | |
MA26630A1 (en) | NOVEL 4-PHENYLPYPERIDINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
FR2794742B1 (en) | NOVEL BENZENE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |